Mirabelli-Badenier M.,Neuropsichiatria Istituto Giannina Gaslini |
Severino M.,Neuroradiologia Istituto Giannina Gaslini |
Tappino B.,Centro Of Diagnostica Genetica ochimica Delle Malattie Metaboliche Istituto Giannina Gaslini |
Tortora D.,University of Chieti Pescara |
And 8 more authors.
Metabolic Brain Disease | Year: 2015
Mucolipidosis type IV (MLIV) is a very rare disorder of late endosome/lysosome transport, characterized by neurodevelopmental abnormalities and progressive visual impairment owing to corneal clouding and retinal dystrophy. Greater than 70 % of MLIV patients are of Ashkenazi Jewish ancestry. Here we report a novel MCOLN1double mutant allele [c.395_397delCTG;c.468_474dupTTGGACC] which introduces a premature stop codon [p.Ala132del; p.Asn159LeufsX27] leading to almost complete abrogation of the region coding mucolipin-1, a member of the transient receptor potential (TRP) cation channel family. The genomic lesion was identified in homozygous state, in a non-Jewish Italian MLIV patient, who also presented abnormal serum gastrin levels. Conventional and advanced MRI sequences, including diffusion tensor imaging and tractography, were used for the assessment of white matter involvement in the patient. © 2014, Springer Science+Business Media New York. Source